Norbert Pardi, PhD
Penn Medicine Provider
About me
- Associate Professor of Microbiology
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
Dr. Pardi is a Penn Medicine physician.
Qualifications and experience
- Academia Europaeca, International
- American Society for Microbiology, National
- American Society of Gene and Cell Therapy, National
- European Scientific Working Group on Influenza and Other Respiratory Viruses (Spain), International
- European Scientific Working group on Influenza and other Respiratory Viruses (ESWI), International
- European Society of Clinical Microbiology and Infectious Diseases, International
- Hungarian Society for Immunology, National
- Keystone Symposium-Nanomedicines, National
- National Institutes of Health, ZRGI BBBT (81) study section, National
- The American Association of Immunologists, National
Treatments and conditions
Research
Publications
Nishida J, Seehawer M, Rojas Jimenez E, Yan P, Bui TM, Foidart P, Muramatsu H, Goyette MA, Cai X, Li Z, Beattie MB, Pardi N, Polyak K. Breast cancer prevention by prophylactic Lalba mRNA-LNP vaccination , Proc Natl Acad Sci, 123(36): 2026,e2621855123
Braun RM, Ferretti MB, Lee JS, Miller J, Castellana L, Acuña J, Whig K, Dohnalová L, Descamps HC, Huber AS, Muramatsu H, Hewins P, Li Y, Bhutda S, Etwebi Z, Dittmar M, Cook T, Schultz DC, Blackshear PJ, Jurado KA, Thaiss CA, Pardi N, Lynch KW, Cherry S. Selective decay of interferon mRNAs controls antiviral immunity and innate memory , Mol Cell, 86(17): 2026,3565-3584
Vadovics M, Pampena MB, Lam K, Lundgreen KA, Muramatsu H, Sárközy A, Ábrahám E, Lipinszki Z, Bates P, Betts MR, Heyes J, Pardi N.* Evaluation of lipid nanoparticle adjuvants with different PEG lipid ratios and phospholipid modifications in non-human primates , Mol Ther Nucleic Acids, 37(3): 2026,102999
Cody EW, Ningoo M, Monga I, Tsankov AM, Muramatsu H, Pardi N, Fribourg M, Heeger PS, Dominguez-Sola D. Complement-regulated homeostatic proliferation controls memory B cell longevity and repertoire composition , J Exp Med, 223(77): 2026,e1014337
Hook LM, Cairns TM, Awasthi S, Egan KP, Gopalakrishnan M, Syeda Z, Pardi N, Bergstrom T, Cohen GH, Friedman HM. HSV-2 gC2 mRNA immunization in mice protects by producing antibodies that bind immune evasion epitopes , PLoS Pathog, 222(6): 2026,e1014337
Sturtz AJ, Evavold BK, Heidari Rarani Z, Alsoussi WB, Zhou JQ, Matz HC, Muramatsu H, Simkins W, Kumar Malladi S, McIntire KM, Das J, Turner JS, Pardi N, Ellebedy AH. BPTF is essential for vaccine-induced germinal center B cell responses , J. Immunol, 215(6): 2026,vkag126
Locci M, Pardi N* Immunological mechanisms of mRNA vaccines for infectious diseases , Nature, 8120(654): 2026,892-901
Sweileh RBA, Pardi N* Silencing the alarm: nucleoside modifications suppress innate immune sensing of RNA , J Immunol, 215(6): 2026,345
Tálas A, Ioannidi EI, Weber Y, Haenggi T, Kulcsár PI, Zürcher N, Faccin E, Moon WJ, Kissling L, Villiger EA, Matsushita M, Rothgangl T, Janjuha S, Lin PJC, Poms M, Muramatsu H, Vadovics M, Reichmuth A, Kopf M, Pardi N, Tam YK, Häberle J, Schwank G. RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I , Sci Transl Med, 18(849): 2026,eaec7274
Janjuha S, Haenggi T, Chamberlain TC, Rothgangl T, Kissling L, Wilhelm M, Mathis N, Boeck D, Marquart K, Ioannidi E, Moon WJ, Muramatsu H, Vadovics M, Pardi N, Semple SC, Tam YK, Schwank G. Spatial profiling of gene editing by in situ sequencing in mice and macaques , Nat Biomed Eng, 10(5): 2026,968-979